Company page

Acrux Limited

Acrux Limited, trading under the ticker ACR, is a publicly listed company on the Australian market with a market capitalization of approximately AUD 5.49 million. The company focuses on developing innovative pharmaceutical products, particularly in the field of transdermal drug delivery. Acrux aims to enhance patient outcomes through its advanced delivery systems and unique formulations.